Image (C087a4a4 Dd45 4b06 8b7c 76be61a8c063 01)
Acetazolamide Tablet
Product Images NDC 68071-3632
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 68071-3632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label 125 mg (C087a4a4 Dd45 4b06 8b7c 76be61a8c063 02)
This text is a label for a medication package containing tablets of Acetazolamide USP, each tablet containing 125 mg of the active ingredient. It provides information on how to dispense the tablets, storage conditions, manufacturer details, and a reminder to keep drugs out of reach of children. The distributor is Viona Pharmaceuticals Inc., located in Cranford, NJ. The label also includes a unique identifier for the product.*
Container Label 250 mg (C087a4a4 Dd45 4b06 8b7c 76be61a8c063 03)
This is a description for acetaZOLAMIDE tablets, USP. Each tablet contains 250 mg of acetazolamide USP and there are 100 tablets in the package. The tablets are prescription-only and should be stored between 20°C to 25°C (68° to 77°F). It is important to keep the package in a child-resistant container and out of reach of children. The medication is manufactured by Zydus Lifesciences Ltd. in Baddi, India, and distributed by Viona Pharmaceuticals Inc. in Cranford, NJ 07016. Please refer to the package insert for complete prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
